Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6030
Source ID: NCT02501343
Associated Drug: Sodium Bicarbonate Oral Capsule
Title: Alkaline Diet for Insulin Sensitivity
Acronym: ADIS
Status: COMPLETED
Study Results: NO
Results:
Conditions: Dysglycemia|Type 2 Diabetes Mellitus
Interventions: DRUG: Sodium Bicarbonate Oral Capsule|DRUG: Placebo
Outcome Measures: Primary: Changes in venous blood pH, The investigators aim is to determine whether venous blood pH decreases after a high acid load meal, and whether this effect is attenuated by administration of sodium bicarbonate prior to a mixed meal study, Baseline (fasting) and 3 hours post meal | Secondary: Changes in glycemic response to the meal, Postprandial glucose excursion will be compared between sodium bicarbonate and placebo, Baseline (fasting) and 3 hours post meal|Changes in insulin response to the meal, Postprandial insulin excursion will be compared between sodium bicarbonate and placebo, Baseline (fasting) and 3 hours post meal|Changes in arterial stiffness, Postprandial arterial stiffness (measured by the augmentation index derived from Sphygmocore, Atcor Medical, Australia) will be compared between sodium bicarbonate and placebo, Baseline (fasting) and 3 hours post meal|Changes in hunger and satiety scores, Postprandial hunger and satiety will be compared between sodium bicarbonate and placebo, Baseline (fasting) and 3 hours post meal
Sponsor/Collaborators: Sponsor: Garvan Institute of Medical Research
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 32
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Start Date: 2015-03
Completion Date: 2016-12
Results First Posted:
Last Update Posted: 2017-03-07
Locations: Garvan Institute of Medical Research, Darlinghurst, New South Wales, 2010, Australia
URL: https://clinicaltrials.gov/show/NCT02501343